These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 34351418)

  • 1. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
    Hoch NC
    Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
    Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
    J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.
    Ribeiro VC; Russo LC; Hoch NC
    EMBO J; 2024 Jul; 43(14):2908-2928. PubMed ID: 38834852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.
    Kar P; Chatrin C; Đukić N; Suyari O; Schuller M; Zhu K; Prokhorova E; Bigot N; Baretić D; Ahel J; Elsborg JD; Nielsen ML; Clausen T; Huet S; Niepel M; Sanyal S; Ahel D; Smith R; Ahel I
    EMBO J; 2024 Jul; 43(14):2929-2953. PubMed ID: 38834853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
    Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
    PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
    Yu L; Liu X; Yu X
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
    Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
    J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
    Alhammad YMO; Fehr AR
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
    Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.
    Rack JGM; Zorzini V; Zhu Z; Schuller M; Ahel D; Ahel I
    Open Biol; 2020 Nov; 10(11):200237. PubMed ID: 33202171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.
    Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M
    Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation.
    Torretta A; Chatzicharalampous C; Ebenwaldner C; Schüler H
    J Biol Chem; 2023 Sep; 299(9):105096. PubMed ID: 37507011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
    Daugherty MD; Young JM; Kerns JA; Malik HS
    PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis.
    Fehr AR; Jankevicius G; Ahel I; Perlman S
    Trends Microbiol; 2018 Jul; 26(7):598-610. PubMed ID: 29268982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antiviral Activities of Poly-ADP-Ribose Polymerases.
    Malgras M; Garcia M; Jousselin C; Bodet C; Lévêque N
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33808354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When PARPs Meet Antiviral Innate Immunity.
    Zhu H; Zheng C
    Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
    Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
    Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
    Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
    SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.
    Tsika AC; Gallo A; Fourkiotis NK; Argyriou AI; Sreeramulu S; Löhr F; Rogov VV; Richter C; Linhard V; Gande SL; Altincekic N; Krishnathas R; Elamri I; Schwalbe H; Wollenhaupt J; Weiss MS; Spyroulias GA
    J Mol Biol; 2022 Aug; 434(16):167720. PubMed ID: 35839840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.